Duration of protective immunity following COVID‐19 vaccination of individuals with underlying health conditions: A rapid review

Kieran Walsh(University College Cork), Michelle O’Neill(Health and Safety Authority), Éamon Ó Murchú(Trinity College Dublin), Helen O’Donnell(Health and Safety Authority), Marie Carrigan(Health and Safety Authority), Mark O’Loughlin(Nenagh Hospital), Karina Butler(Our Lady's Hospital), Karen Cardwell(Health and Safety Authority), Joan Quigley(Boston University), Laura Comber(Health and Safety Authority), Natasha Broderick(Health and Safety Authority), Máirín Ryan(University College Dublin), Patricia Harrington(Health and Safety Authority), Katie M. O’Brien(Health and Safety Authority), Susan M. Smith(Trinity College Dublin), Jingjing Jiang(Health and Safety Authority), Heather Eames(Health and Safety Authority), Kevin Connolly(Royal College of Physicians of Ireland), Brenda Corcoran(Royal College of Physicians of Ireland), Kirsty O’Brien(Health and Safety Authority)
Reviews in Medical Virology
February 3, 2024
10.1002/rmv.2504
Cited by 3

Related Papers

Multimorbidity
|Nature Reviews Disease Primers|2022|1.3k
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings
|Cochrane Database of Systematic Reviews|2016|888
Association between electronic cigarette use and tobacco cigarette smoking initiation in adolescents: a systematic review and meta-analysis
|BMC Public Health|2021|313
Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations
|BMJ Open|2022|240
Interventions for improving outcomes in patients with multimorbidity in primary care and community setting: a systematic review
|Systematic Reviews|2021|209